Effective Treatment of Hemophagocytic Lymphohistiocytosis Linked to Scrub Typhus Using Doxycycline and Immunomodulatory Therapy: A Case Study - Report - MDSpire

Effective Treatment of Hemophagocytic Lymphohistiocytosis Linked to Scrub Typhus Using Doxycycline and Immunomodulatory Therapy: A Case Study

  • By

  • Hua, Yuanyuan

  • Zhang, Yan

  • Zhou, Jimin

  • Shi, Yan

  • Xu, Feng

  • April 17, 2026

Share

Clinical Report: Effective Treatment of Hemophagocytic Lymphohistiocytosis Linked to Scrub Typhus

Overview

This case report details the successful management of hemophagocytic lymphohistiocytosis (HLH) associated with scrub typhus in a 14-year-old boy. Treatment with doxycycline and immunomodulatory therapy resulted in rapid clinical improvement and full recovery.

Background

Hemophagocytic lymphohistiocytosis is a severe hyperinflammatory syndrome that can be triggered by infections such as scrub typhus. Early recognition and treatment are critical, as delayed diagnosis can lead to significant morbidity and mortality. Understanding the clinical features and effective management strategies for HLH in the context of scrub typhus is essential for improving patient outcomes.

Data Highlights

Laboratory findings included hyperferritinemia (>3000 ng/mL), hypofibrinogenemia, and hemophagocytosis on bone marrow aspirate, fulfilling HLH-2004 diagnostic criteria.

Key Findings

  • A 14-year-old boy presented with prolonged fever, cough, and lethargy, with a pathognomonic eschar indicative of scrub typhus.
  • Laboratory results met HLH-2004 criteria, confirming secondary HLH due to scrub typhus.
  • Immediate treatment with doxycycline and immunomodulatory therapy led to fever resolution within 72 hours.
  • Rapid declines in platelets and fibrinogen, along with increases in ferritin and LDH, should prompt HLH evaluation in scrub typhus cases.
  • Combined therapy targeting the infection and cytokine storm may improve outcomes in HLH associated with scrub typhus.

Clinical Implications

Clinicians should maintain a high index of suspicion for HLH in pediatric patients presenting with scrub typhus, especially when laboratory markers indicate rapid deterioration. Early initiation of doxycycline and immunomodulatory therapy can significantly enhance recovery prospects.

Conclusion

This case underscores the importance of prompt diagnosis and treatment of HLH in the context of scrub typhus, emphasizing a dual approach to manage both infection and hyperinflammation.

Related Resources & Content

  1. Blood Cancer Journal, 2024 -- Efficacy of Emapalumab and Ruxolitinib in Treating Haemophagocytic Lymphohistiocytosis Patients
  2. Infection, 2024 -- Notch Pathway Activation in Scrub Typhus Patients: Links to Organ Dysfunction and Adverse Outcomes
  3. The Journal of Infectious Diseases, 2024 -- C-C Motif Ligand 7 and C-C Motif Chemokine Receptor 3 Dysregulation in Patients With Scrub Typhus and Association With Mortality
  4. Open Forum Infectious Diseases, 2024 -- Characteristics and Laboratory Findings of Hemophagocytic Lymphohistiocytosis in Patients with Disseminated Histoplasmosis
  5. Scrub typhus-associated hemophagocytic lymphohistiocytosis among healthy children: A case series from northern Thailand - PubMed, 2025
  6. Hemophagocytic lymphohistiocytosis in adults - PubMed, 2025
  7. Frontiers, 2026 -- Successful Management of Scrub Typhus-Associated Hemophagocytic Lymphohistiocytosis with Doxycycline and Immunomodulation: A Case Report
  8. Scrub typhus-associated hemophagocytic lymphohistiocytosis among healthy children: A case series from northern Thailand - PubMed
  9. Hemophagocytic lymphohistiocytosis in adults - PubMed
  10. Frontiers | Successful Management of Scrub Typhus-Associated Hemophagocytic Lymphohistiocytosis with Doxycycline and Immunomodulation: A Case Report

Original Source(s)

Related Content